0.06
0.06 (0%)
As of Feb 14, 2025
T2 Biosystems, Inc. [TTOO]
Source:
Company Overview
T2 Biosystems, Inc is an vitro diagnostics company and leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes. We are dedicated to improving patient care and reducing the cost of care by helping clinicians effectively treat patients faster than ever before.
| Country | United States |
| Headquarters | lexington, massachusetts |
| Phone Number | 781-457-1200 |
| Industry | manufacturing |
| CEO | John Sperzel |
| Website | t2biosystems.com. |
Financial Year:
Financial Overview (Dollars in Millions)
| Revenue | $2 |
| Operating Profit | $-10.2 |
| Net Income | $-10.1 |
| Net Cash | $-13.6 |
Profit Ratios
| Gross Margin | $2 |
| Operating Margin | -511.9 |
| Profit as % of Revenues | -19.6% |
| Profit as % of Assets | -100.8% |
| Profit as % of Stockholder Equity | 86.4% |
Management Effectiveness
| Return on Equity | 86.4% |
| Return on Assets | -56% |
| Turnover Ratio | 19.8% |
| EBITA | $-10.2 |
Balance Sheet and Cash Flow Measures
| Total Assets | $18.1 |
| Total Liabilities | $29.8 |
| Operating Cash Flow | $-27.2 |
| Investing Cash Flow | $0 |
| Financing Cash Flow | $13.6 |
